Yakmun Yakdap Co., Ltd. (CEO: Jeong-rae Jo), an AI-based drug management solution company, announced on July 31 that it signed a ‘MOU to improve the quality of AI-based comprehensive drug management services’ with the Gyeonggi Pharmaceutical Association (Chairman: Je-deok Yeon).
This agreement marks the official adoption of a drug management AI solution by a nationwide pharmacist association. Yakmunyakdap will provide its drug management AI service, "PhAI," to approximately 5,800 pharmacies in Gyeonggi Province. This represents approximately 23% of all pharmacies nationwide, making Yakmunyakdap the largest-scale implementation of drug management AI in Korea.
PhAI is an AI service that offers comprehensive drug management capabilities, including prescription review, medication guidance generation, and patient medication management. Its unique feature is its ability to review multiple medications (20 or more), reducing the average pharmacist's drug review time from over two hours to under five minutes. The system was developed through industry-academia collaboration with the Clinical Pharmacy Laboratory at Seoul National University's College of Pharmacy and incorporates clinically-based review expertise.
The strength of Yakmunyakdap lies in its pharmacist-focused development. Pharmacists participated in its planning and development, and they are directly involved in improving the quality of AI reviews. Going forward, the system will be integrated with a pharmacist-specific knowledge exchange platform used by over 34,000 pharmacists, incorporating field feedback and continuously accumulating medication management data.
Yeon Je-deok, president of the Gyeonggi Pharmaceutical Association, said, “AI technology will not replace the expertise of pharmacists, but rather serve as a supporting tool, helping pharmacists focus on patient consultations,” adding, “I expect that this will enable us to provide better pharmaceutical services to local residents.”
“PhAI was designed as a professional tool for pharmacists, and its goal is to deliver real value to patients through pharmacist verification,” said Cho Jeong-rae, CEO of Yakmun Yakmdap. “Starting with our collaboration with the Gyeonggi Pharmaceutical Association, we will expand the service to pharmacies nationwide.”
Under this agreement, the two parties will jointly pursue ▲the introduction and advancement of an AI system to assist pharmacists in visiting drugstores and multi-drug consultations, ▲the development of pharmaceutical IT solutions necessary for an integrated care environment, and ▲the evaluation of successful drug management cases and economic feasibility.
You must be logged in to post a comment.